2493 : A Phase II Study of Concurrent Chemo-Radiation (CXRT) With Irinotecan and Carboplatin Followed by Consolidation Docetaxel for Stage III Non-Small Cell Lung Cancer (NSCLC): Initial Outcome and Toxicity Results